Compare KEQU & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KEQU | PYPD |
|---|---|---|
| Founded | 1906 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.9M | 86.6M |
| IPO Year | 1995 | 2014 |
| Metric | KEQU | PYPD |
|---|---|---|
| Price | $37.12 | $4.45 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $12.25 |
| AVG Volume (30 Days) | 3.2K | ★ 55.7K |
| Earning Date | 03-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.09 | N/A |
| Revenue | ★ $138,558,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $17.70 | ★ N/A |
| Revenue Growth | ★ 7.72 | N/A |
| 52 Week Low | $30.33 | $2.44 |
| 52 Week High | $60.89 | $5.12 |
| Indicator | KEQU | PYPD |
|---|---|---|
| Relative Strength Index (RSI) | 57.60 | 49.08 |
| Support Level | $37.04 | $4.26 |
| Resistance Level | $41.26 | $5.05 |
| Average True Range (ATR) | 0.87 | 0.19 |
| MACD | 0.41 | -0.00 |
| Stochastic Oscillator | 74.62 | 41.67 |
Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.